New patent expiration for the drug Medicure AGGRASTAT – DrugPatentWatch
Annual Drug Patent Expiration for AGGRASTAT
Aggrastat is a drug marketed by Medicure and is included in two NDAs. It is available from a single supplier. There is one patent protecting this drug and two Paragraph IV challenges.
Drug patent litigation for AGGRASTAT.
This drug has five patent family members in five countries.
The generic ingredient in AGGRASTAT is tirofiban hydrochloride. One registered supplier for this compound. Additional details are available on the tirofiban hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Make Better Decisions with DrugPatentWatch
» Start Your Free Trial Today «
Copyright © DrugPatentWatch. Originally published on expiry of a new patent for the drug Medicure AGGRASTAT